Text Size
3708 studies found for:    Lung Diseases, Obstructive: Clinical trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Lung Diseases, Obstructive: Clinical trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
2 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Osteoporosis;   Chronic Obstructive Pulmonary Disease (COPD);   Osteopenia
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
3 Recruiting Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation
Conditions: Weaning of Mechanical Ventilation;   Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial;   Procedure: Pressure Support Ventilation
4 Completed A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions: COPD;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Collection of safety data for Cohort 1
5 Active, not recruiting The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids;   Other: Placebo
6 Completed Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Prednisolone
7 Enrolling by invitation European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: COPD evidence based care pathway
8 Recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo
9 Completed
Has Results 		26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   COPD;   Lung Diseases, Obstructive
Interventions: Drug: Indacaterol;   Drug: Formoterol (12 µg b.i.d.);   Drug: Tiotropium (18 µg o.d.);   Drug: Placebo to Indacaterol;   Drug: Placebo to Formoterol
10 Completed A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719
11 Completed Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
12 Completed 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
13 Completed
Has Results 		Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Formoterol (OT)
14 Completed
Has Results 		Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
15 Completed
Has Results 		1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Glycopyrronium bromide;   Drug: Placebo to glycopyrronium bromide;   Drug: Tiotropium
16 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
17 Completed A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Chronic Obstructive Airway Disease
Interventions: Drug: GW856553;   Drug: Placebo;   Drug: Seretide
18 Active, not recruiting Long-term Safety Study for GSK573719/GW642444 in Japanese
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GSK573719/GW642444 Inhalation Powder
19 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
20 Completed Discharge Coordinator Intervention in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Coordinated discharge;   Other: Control
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years